Clinical evaluation of AMVISC(R) as a Vicodlastic Substance in Extracapsular Cataract Extraction with Intracoular lens Implantation.
- Author:
Seung Koo KAHNG
1
;
Man Soo KIM
;
Jae Ho KIM
Author Information
1. Department of Ophthalmology, Kangnam St. Mary's Hospital, Catholic University, Medical College, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
AMVISC(R);
Healon(R);
operative efficacy;
inflammation;
intraocular pressure;
corneal endothelial damage;
corneal thickness
- MeSH:
Cataract Extraction*;
Cataract*;
Humans;
Inflammation;
Intraocular Pressure;
Lens Implantation, Intraocular
- From:Journal of the Korean Ophthalmological Society
1989;30(2):185-193
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The effects of AMVISC(R) and Healon(R) in patients undergoing extracapsular cataract extraction with intraocular lens implantation were compared to the operative efficiency and postoperative reactions namely, inflammation, intraocular pressure, corneal endothelial damage, and corneal thickness. During the course of the cataract operations, twenty eyes received AMVISC(R) and twenty eyes received Healon(R). The AMVISC(R) and Healon(R) were all aspirated from anterior and posterior cha mbers by means of the irrigation and aspiration system at the end of the procedure. There were no significant difference in operative efficacy and postoperative reactions between AMVISC(R) group and Healon(R) group.
